David Hull

Lawyer, Van Bael & Bellis

David Hull practises EU competition law.

David has a wide range of experience as an EU competition lawyer, having started practising in Brussels in 1984.

David specialises in representing clients in complex investigations before the European Commission and in litigation before the EU Courts.

Notable cases include: Lundbeck (“reverse payment” patent settlements); Cathode Ray Tubes (appeal of cartel decision); Ryanair (appeal of Commission decision blocking takeover of Aer Lingus); Akzo (landmark case on legal privilege); Bitumen (appeal of cartel decision) and Microsoft (appeal of fine for alleged non-compliance with Commission decision).

David has in-depth experience in the life sciences sector. He has successfully represented leading life science companies in major EU investigations and regularly advises them on life cycle management issues, European parallel trade and distribution issues (including co-marketing and co-promotion agreements), discount | rebate schemes, collaboration arrangements, IP licensing and mergers.

Contributed to

1

Competition law in the pharmaceutical sector

Practice notes

This Practice Note covers the application of EU and UK competition law to common practices that take place within the pharmaceutical sector. After explaining the definition of market as it applies to the sector, it considers reverse payment patent settlements, pricing strategy, parallel trade, misleading conduct, misuse of regulatory procedures, R&D collaboration agreements as well as mergers and acquisitions.

Life Sciences